Xianju Pharma

Xianju Pharma, established in 1972, is a prominent entity within the global pharmaceutical and healthcare sectors. The company specializes in the development and supply of active pharmaceutical ingredients, focusing on customized solid-state specifications and robust intellectual property frameworks. By maintaining a commitment to high-quality manufacturing standards, Xianju Pharma has positioned itself as a reliable partner for international B2B pharmaceutical collaborations. The organization leverages its extensive experience to navigate complex regulatory environments while ensuring consistent product efficacy and safety for its diverse client base.

Operating with a workforce of 1,000-5,000 employees, the company maintains a strategic footprint across 3 distinct locations. This operational scale allows for efficient production cycles and streamlined supply chain management. Meet Xianju Pharma's team to gain insights into the leadership and technical expertise driving their ongoing innovation in pharmaceutical synthesis. The company’s infrastructure is designed to support large-scale manufacturing requirements, ensuring that they meet the rigorous demands of the global healthcare market while maintaining strict adherence to international quality protocols and operational excellence.

Xianju Pharma is publicly traded under the ticker SSE: 2332, reflecting its established market presence and financial stability. With an annual revenue of $577.5M, the firm demonstrates significant commercial viability and growth potential within the competitive pharmaceutical landscape. Their focus on specialized chemical synthesis and API production continues to attract global interest, reinforcing their status as a key player in the Asia-Pacific region. By prioritizing research and development alongside scalable manufacturing, the company remains well-equipped to address evolving healthcare challenges and sustain its long-term growth trajectoryView more...